Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50

United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Insider

Date

Role

Action

Price

Amount

Eric M Dube

15 Oct 2026

Chief Executive Officer

Sold after exercise

78,400

$55.02

$4.31M

Eric M Dube

15 Oct 2026

Chief Executive Officer

Sold after exercise

37,270

$54.20

$2.02M

Eric M Dube

15 Oct 2026

Chief Executive Officer

Sold after exercise

128,065

$52.97

$6.78M

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 3

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 243,735

History held since 26 Dec 2012